Nivea develops cosmetic sunscreen for child erythropoietic protoporphyria sufferer 

Nivea develops cosmetic sunscreen for child erythropoietic protoporphyria sufferer 

THE WHAT? Beiersdorf-owned Nivea has created a cosmetic sunscreen for a child sufferer of the condition erythropoietic protoporphyria (EPP). 

THE DETAILS After being contacted by the child’s parents, NIVEA and Beiersdorf’s Chief Scientist for Photobiology Dr. Ludger Kolbe launched a research project, alongside Kolbe’s team.

When EPP sufferers skin comes into direct contact with the visible, colored components of sunlight, a genetic defect causes neuropathic pain and triggers burns on the skin.

According to a press release, when applied thickly, the protective function of the sunscreen allows the child to stay in direct sunlight for a short time.

THE WHY? While the sunscreen was developed specifically for the child and not part of Beiersdorf’s product portfolio or for sale, with the onslaught of climate change, such product formulations may become in greater demand. 

Kolbe says: “With the high standards of skin protection that we at NIVEA pursue, we are delighted that we were able to find a special solution for Charlotte. With her personal sunscreen, she still has to be careful in the sun, but can spend a little longer playing outside with her friends.”

Embrace the Sun: Your Ultimate Summer Skincare Routine

WELLNESS

FASHION

TRAVEL

PROFESSIONAL BEAUTY

JOBS & PEOPLE